Newcastle disease virus selectively kills human tumor cells

DePace, 1912, Sulla scomparsa di un enorme cancro vegetante del callo dell'utero senza cura chirurgica, Ginecologia, 9, 82 Salmon, 1922, Vaccine variolique dans le cancer, Compt. Rend. Soc. Biol., 86, 819 Webb, 1970, Viruses in the treatment of cancer, Lancet, 1, 1206, 10.1016/S0140-6736(70)91790-3 Moore, 1954, Effects of viruses on tumors, Annu. Rev. Microbiol., 8, 393, 10.1146/annurev.mi.08.100154.002141 Southam, 1960, Present status of oncolytic virus studies, Trans. N.Y. Acad. Sci., 22, 657, 10.1111/j.2164-0947.1960.tb00739.x Pasquinucci, 1971, Possible effect of measles on leukemia, Lancet, 1, 136, 10.1016/S0140-6736(71)90869-5 Gross, 1971, Measles and leukemia, Lancet, 1, 397, 10.1016/S0140-6736(71)92232-X Bluming, 1971, Regression of Burkitt's Lymphoma in association with measles infection, Lancet, 2, 105, 10.1016/S0140-6736(71)92086-1 Csatary, 1971, Viruses in the treatment of cancer, Lancet, 2, 825, 10.1016/S0140-6736(71)92788-7 Asada, 1974, Treatment of human cancer with mumps virus, Cancer, 34, 1907, 10.1002/1097-0142(197412)34:6<1907::AID-CNCR2820340609>3.0.CO;2-4 Cassel, 1965, Newcastle Disease Virus as an antineoplastic agent, Cancer, 18, 863, 10.1002/1097-0142(196507)18:7<863::AID-CNCR2820180714>3.0.CO;2-V Cassel, 1977, Viral oncolysate in the management of malignant melanoma. I. Preparation of the oncolysate and measurement of the immunologic responses, Cancer, 40, 672, 10.1002/1097-0142(197708)40:2<672::AID-CNCR2820400213>3.0.CO;2-Y Murray, 1977, Viral oncolysate in the management of malignant melanoma. II. Clinical studies, Cancer, 40, 680, 10.1002/1097-0142(197708)40:2<680::AID-CNCR2820400214>3.0.CO;2-# Cassel, 1983, A phase II study on the postsurgical management of stage II malignant melanoma with a Newcastle Disease Virus oncolysate, Cancer, 52, 856, 10.1002/1097-0142(19830901)52:5<856::AID-CNCR2820520519>3.0.CO;2-4 Schirrmacher, 1991, Design of a virus-modified autologous tumor vaccine for active-specific immunotherapy of cancer metastasis, Arch. Geschwulstforsch., 61, 23 Bohle, 1990, Postoperative active specific immunization in colorectal cancer patients with virus-modified autologous tumor-cell vaccine, 66, 1517 Faaberg, 1988, Strain variation and nuclear association of Newcastle disease virus matrix protein, J. Virol., 62, 586, 10.1128/JVI.62.2.586-593.1988 Schirrmacher, 1986, Successful application of a non-oncogenic virus for anti-metastatic cancer immunotherapy, Cancer Rev., 5, 19 Lorence, 1988, Newcastle disease virus as an antineoplastic agent: Induction of tumor necrosis factor-alpha and augmentation of its cytotoxicity, J. Nat. Cancer Inst., 80, 1305, 10.1093/jnci/80.16.1305 Ho, 1970, Factors influencing the interferon response, Arch. Int. Med., 126, 136, 10.1001/archinte.126.1.135 Merigan, 1970, Clinical studies employing interferon inducers in man and animals, Ann. NY Acad. Sci., 173, 746, 10.1111/j.1749-6632.1970.tb53468.x DeVita, 1989, Principles of chemotherapy, 276 Ginsberg, 1980, Paramyxovirus, 1139 Alexander, 1988, Newcastle disease: Methods of spread, 256